A Medtronic shareholder is reportedly looking to block the pending, $43 billion merger with Covidien, arguing that the deal leaves stockowners on the hook for significant tax liabilities.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1lzX45z
Cap comentari:
Publica un comentari a l'entrada